Company Overview and News

85
10 Best Blue-Chip Stocks for Mid-Career Investors

19h investorplace - 2
Workers in their 30s and 40s often find themselves in tricky situations, career-wise. They’re certainly beyond their trainee days, but not yet in positions only awarded to employees with a wealth of experience and proven acumen. It’s in this time of life when workers find themselves on a clear path to some sort of senior position, or realize it’s just not going to happen.
QRVO MA PYPL AMD NVDA WMT ADBE AMZN AMT MRK GOOGL MSFT CAH INTC

6
Cardinal Health: The Spring Is Loading

2018-09-13 seekingalpha - 1
Dublin, Ohio,-based healthcare distributor Cardinal Health (CAH) has been under a bit of “distress” lately. Just to give you a sampling, adjusted company-wide earnings are down about 9% year-over-year, drug pricing has been under pressure and the security’s share price has gone from a high above $90 back in 2015 all the way down to today’s mark closer to $53, a ~40% decline.
VALU CAH

8
Abercrombie & Fitch Co. Appoints General Counsel

2018-09-13 globenewswire
NEW ALBANY, Ohio, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE: ANF) today announced the appointment of Gregory J. Henchel as senior vice president and general counsel. Mr. Henchel brings 25 years of broad legal experience to the company, including more than ten years in the retail sector. Henchel’s experience spans general corporate, commercial, securities, regulatory, employment and intellectual property law, corporate governance and litigation.
ANF CAH

20
John And Jane's August Dividend Increases And Income Tracker - Taxable Account

2018-09-13 seekingalpha
August marks the 10th month I have officially tracked the taxable account's dividend income. The total amount of dividend income received was $1,665.95.
SOJA GIS XOM IDCC SKT LTC ENB OPRF BPL SEP COP MIC CINF AAPL CAH EMR SO TLP WLK O MSB CMI WLKP ENB ETP HP ORI SPG WPC ADM

5
Nevada prisons drug buyer knew firms opposed execution use

2018-09-13 nzherald.co.nz
LAS VEGAS (AP) — Nevada's prisons pharmacy chief testified Wednesday that she obtained drugs for the lethal injection of a convicted killer despite knowing that drug manufacturers didn't want their products used for executions.
CAH

40
Aceto 72% Target Net Gain Tops WallStar Healthcare Equities For September

2018-09-12 seekingalpha
But for PMD, Big pharma drug makers and biotech continued to top the healthcare sector by yield and broker targets. WallStars are distinguished by positive broker target price upsides.
GRFS ACET GILD AZN MCK CVS GSK SNY AZN AGN PMD NVS GSK ABBV CAH PFE ABBV

25
Amazon Vs. McKesson And Its Pharma Distribution Peers

2018-09-12 seekingalpha
Amazon's main goal in pharmaceuticals is likely to build consumer relationships in retail rather than disrupt distribution.
BRK.A ABC MCK CAH CVS

10
In Negotiations of 1,000 Opioid Lawsuits, Purdue Pharma Offers Free Opioid Therapy

2018-09-12 biospace
Purdue Pharma, best known for being the manufacturer of opioid drug OxyContin, is offering free doses of a treatment for opioid abuse as part of negotiations in more than 1,000 lawsuits.
MCK CAH

150
85% of insured Amazon Prime members open to buying drugs on the site, Deutsche Bank says

2018-09-11 cnbc
The vast majority of Amazon Prime members who have health insurance told Deutsche Bank that they would be willing to purchase prescription drugs on the online retailer's website.
BRK.A DB RAD CAH CVS

5
Cardinal Health: Technical Analysis And Valuation

2018-09-10 seekingalpha
With a healthy 3.7% dividend, investors can sit back and accumulate dividends while they wait for the capital appreciation.
CAH

13
Cardinal Health Stock Is Ready to Offer Healthy Profits for Investors

2018-09-10 investorplace
After a downward trend for the stock price in 2018, investors may consider adding Cardinal Health (NYSE:CAH) stock to their portfolio for the rest of the year. There are several long strategies in CAH stock that could lead to impressive profits.
ABC MCK OMI CAH

5
CAH / Cardinal Health, Inc. 8-K (Current Report)

2018-09-07 sec.gov
Document UNITED STATES
CAH

11
Cardinal Health And Generic Price Deflation

2018-09-06 seekingalpha - 1
Cardinal Health has fallen out of favor with Wall Street due to Generic Drug Price Deflation. I explain why that is shortsighted.
MCK CAH

5
Why Is Cardinal (CAH) Up 0.9% Since Last Earnings Report?

2018-09-05 zacks
It has been about a month since the last earnings report for Cardinal Health (CAH - Free Report) . Shares have added about 0.9% in that time frame, underperforming the S&P 500.
CAH

10
McKesson's Valuation From 3 Perspectives

2018-09-04 seekingalpha
In this article, I will take a quantitative approach to analyzing MCK. This piece will solely focus on the numerical value of the business from three different perspectives.
MCK CAH

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to CAH / Cardinal Health, Inc. on message board site Silicon Investor.

VCAH VCAH VCAH
CUSIP: 14149Y108